Published in FDA Law Weekly, June 21st, 2007
Total contract value: USD 1.6 billion
The total value of the deal, including contractual options, is USD 1.6 billion, of which the base contract amounts to USD 500 million. In addition to the delivery of 20 million doses of IMVAMUNE(R), the base contract will support additional research and development of the product to fulfil the requirements for the potential use of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.